Publications by authors named "F Divanon"

Claim this Profile
U
UHPLC-MS/MS method for the quantification of ultra-traces of irinotecan and its metabolites in red blood cells and plasma to detect caregivers' contamination.
Simon Rodier, Guillaume Saint-Lorant, Marc Since, Stéphanie Lagadu, Hubert Benoist, Fabienne Divanon

Drug Test Anal· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perception, knowledge, practices and training regarding the risk of exposure to antineoplastic drugs in three French compounding units.
Clémence Delafoy, Hubert Benoist, Michèle Vasseur, Cécile Breuil, Fabienne Divanon

J Oncol Pharm Pract· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Quality management of the experimental health products circuit in hospital pharmacies: National inventory and proposed standardised tools].
E Delavoipière, C Bouglé, G Saint-Lorant, F Divanon, A Alix

Ann Pharm Fr· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood contamination of the pharmaceutical staff by irinotecan and its two major metabolites inside and outside a compounding unit.
Victoire Béchet, Hubert Benoist, Frédéric Beau, Fabienne Divanon, Stéphanie Lagadu

J Oncol Pharm Pract· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perception, knowledge, and handling practice regarding the risk of exposure to antineoplastic drugs in oncology day hospitalization units and compounding unit staff.
Hubert Benoist, Amandine Busson, Audrey Faveyrial, Karine Bouhier-Leporrier, Fabienne Divanon

J Oncol Pharm Pract· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis